United States

A statement from Dr. Neil Schluger, Senior Advisor for Science, Vital Strategies on Altria’s purchase of a major stake in Juul, the company widely responsible for the explosive growth in vaping among youth in the United States.

As a partner in the new $50 million investment from Bloomberg Philanthropies, Vital Strategies will support governments and communities in U.S. states to reduce overdose deaths, now the leading cause of death for people under 50 in the U.S.

Statement from Dr Neil Schluger, Senior Advisor for Science at Vital Strategies, on the U.S. Food and Drug Administration’s proposals to restrict flavored tobacco products, including a potential ban on menthol in cigarettes, and restrictions on the sale of fruit- or sweet-flavored e-cigarette liquid.

The study finds that 17 year-olds who use e-cigarettes are more likely to use both e-cigarettes and regular cigarettes by the age of 19.

We welcome news that the Food and Drug Administration (FDA) has given five makers of popular vaping devices - Juul Labs, RJR Vapor, Altria Group, Imperial Brands and Logic – 60 days to prove they can keep their products away from minors.

The petition follows a two-year investigation, that found tobacco companies are paying young social media influencers with large audiences to post images of cigarettes and smoking and promote tobacco industry-sponsored events, contests and online promotions.

Vital Strategies has welcomed an announcement from the U.S. Food and Drug Administration (FDA) regarding its intention to decrease the burden of tobacco-related harm in the USA by regulating nicotine levels and, potentially, flavorings in tobacco products.